The ideal contrast agents for ventilation SPECT and MRI are Technegas and Xe gas, respectively. Despite increasing interest in the clinical utility of ventilation imaging, these modalities have not been directly compared. Therefore, our objective was to compare the ventilation defect percent (VDP) assessed by Technegas SPECT and hyperpolarized Xe MRI in patients scheduled to undergo lung cancer resection with and without pre-existing obstructive lung disease. Forty-one adults scheduled to undergo lung cancer resection performed same-day Technegas SPECT, hyperpolarized Xe MRI, spirometry, and diffusing capacity of the lung for carbon monoxide (DL). Ventilation abnormalities were quantified as the VDP using two different methods: adaptive thresholding (VDP) and k-means clustering (VDP). Correlation and agreement between VDP quantified by Technegas SPECT and Xe MRI were determined by Spearman correlation and Bland-Altman analysis, respectively. VDP measured by Technegas SPECT and Xe MRI were correlated (VDP: r = 0.48, = 0.001; VDP: r = 0.63, < 0.0001). A 2.0% and 1.6% bias towards higher Technegas SPECT VDP was measured using the adaptive threshold method (VDP: 23.0% ± 14.0% vs. 21.0% ± 5.2%, = 0.81) and k-means method (VDP: 9.4% ± 9.4% vs. 7.8% ± 10.0%, = 0.02), respectively. For both modalities, higher VDP was correlated with lower FEV/FVC (SPECT VDP: r = -0.38, = 0.01; MRI VDP: r = -0.46, = 0.002) and DL (SPECT VDP: r = -0.61, < 0.0001; MRI VDP: r = -0.68, < 0.0001). Subgroup analysis revealed that VDP measured by both modalities was significantly higher for participants with COPD (n = 13) than those with asthma (n = 6; SPECT VDP: = 0.007, MRI VDP: = 0.006) and those with no history of obstructive lung disease (n = 21; SPECT VDP: = 0.0003, MRI VDP: = 0.0003). The burden of ventilation defects quantified by Technegas SPECT and Xe MRI VDP was correlated and greater in participants with COPD when compared to those without. Our observations indicate that, despite substantial differences between the imaging modalities, quantitative assessment of ventilation defects by Technegas SPECT and Xe MRI is comparable.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206636 | PMC |
http://dx.doi.org/10.3389/fphys.2023.1133334 | DOI Listing |
Introduction: Smokers frequently display respiratory symptoms despite the fact that their pulmonary function tests (PFTs) can be normal. Quantitative lung ventilation single-photon emission computed tomography (SPECT/CT) can provide a quantification of lung ventilatory homogeneity and could prove useful as an early marker of airway disease in smokers. We measured the effects of smoking on regional ventilation distribution in subjects with normal lung function and evaluated whether ventilation distribution in these subjects is related to lung function tests results and clinical symptoms.
View Article and Find Full Text PDFJ Allergy Clin Immunol Pract
April 2024
Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, University of Newcastle, New Lambton Heights, New South Wales, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, New South Wales, Australia; School of Nursing and Midwifery, University of Newcastle, Callaghan, New South Wales, Australia.
Background: Ventilation heterogeneity (VH) is a feature of asthma and indicates small airway disease. Nuclear imaging methods assess VH, which can facilitate clinical diagnosis and further our understanding of disease aetiology.
Objective: We sought to assess VH in severe eosinophilic asthma (SEA) using ventilation/perfusion single-photon emission computed tomography (V/P SPECT), and to assess its use as an objective test of the effect of biologic treatment for ventilation defects in SEA.
Front Physiol
April 2023
Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada.
The ideal contrast agents for ventilation SPECT and MRI are Technegas and Xe gas, respectively. Despite increasing interest in the clinical utility of ventilation imaging, these modalities have not been directly compared. Therefore, our objective was to compare the ventilation defect percent (VDP) assessed by Technegas SPECT and hyperpolarized Xe MRI in patients scheduled to undergo lung cancer resection with and without pre-existing obstructive lung disease.
View Article and Find Full Text PDFJ Nucl Med Technol
March 2023
Royal North Shore Hospital and University of Sydney, Sydney, New South Wales, Australia.
Ventilation and perfusion (V/Q) lung scintigraphy has been used in the assessment of patients with suspected pulmonary embolism for more than 50 y. Advances in imaging technology make SPECT and SPECT/CT feasible. This article will examine the application and technical considerations associated with performing 3-dimensional V/Q SPECT and the contribution of a coacquired CT scan.
View Article and Find Full Text PDFFront Oncol
May 2022
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Radiation Oncology, Beijing, China.
Purpose: The current algorithms for measuring ventilation images from 4D cone-beam computed tomography (CBCT) are affected by the accuracy of deformable image registration (DIR). This study proposes a new deep learning (DL) method that does not rely on DIR to derive ventilation images from 4D-CBCT (CBCT-VI), which was validated with the gold-standard single-photon emission-computed tomography ventilation image (SPECT-VI).
Materials And Methods: This study consists of 4D-CBCT and 99mTc-Technegas SPECT/CT scans of 28 esophagus or lung cancer patients.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!